A physical model for the size-dependent cellular uptake of nanoparticles modified with cationic surfactants

International Journal of Nanomedicine

Volumn 7, Issue , 2012, Pages 3547-3554

  Xu, Airen ^a   Yao, Mingfei ^b   Xu, Guangkui ^c   Ying, Jingyan ^a   Ma, Weicheng ^a   Li, Bo ^b   Jin, Yi ^b  

^a Ningbo Urinary and Renal Diseases Hospital   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c TSINGHUA UNIVERSITY   (China)

Author keywords

Cellular uptake; Coumarin 6; Deserno's model; Nanoparticles

Indexed keywords

COUMARIN 6; COUMARIN DERIVATIVE; DIDODECYLDIMETHYLAMMONIUM BROMIDE; NANOPARTICLE; PACLITAXEL; POLYGLACTIN NANOPARTICLE; POLYVINYL ALCOHOL; UNCLASSIFIED DRUG;

ARTICLE; BENDING ENERGY; CELL INTERACTION; CELL STRAIN CACO 2; CELL STRAIN HT29; CHEMICAL MODIFICATION; CHEMICAL PARAMETERS; CHEMICAL PHENOMENA; COLON ADENOCARCINOMA; COLORECTAL CARCINOMA; CONTROLLED STUDY; DRUG BIOAVAILABILITY; ENCAPSULATION EFFICIENCY; ENDOCYTOSIS; HUMAN; HUMAN CELL; HYDROPHOBICITY; IN VITRO STUDY; INTESTINE MUCOSA PERMEABILITY; MOLECULAR DYNAMICS; PARTICLE SIZE; PHYSICAL CHEMISTRY; PHYSICAL MODEL; STATIC ELECTRICITY; STRETCHING ENERGY; SURFACE MODIFICATION; ZETA POTENTIAL;

CACO-2 CELLS; CATIONS; COUMARINS; EMULSIONS; HT29 CELLS; HUMANS; LACTIC ACID; MICROSCOPY, FLUORESCENCE; NANOPARTICLES; PARTICLE SIZE; POLYGLYCOLIC ACID; QUATERNARY AMMONIUM COMPOUNDS; STRUCTURE-ACTIVITY RELATIONSHIP; SURFACE-ACTIVE AGENTS; THIAZOLES;

EID: 84867011143     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S32188     Document Type: Article

References (33)

1. Ankola DD, Viswanad B, Bhardwaj V, Ramarao P, Kumar MN. Development of potent oral nanoparticulate formulation of coenzyme Q10 for treatment of hypertension: can the simple nutritional supplements be used as first line therapeutic agents for prophylaxis/therapy? Eur J Pharm Biopharm. 2007;67(2):361-369.
2. Mittal G, Sahana DK, Bhardwaj V, Ravi Kumar MN. Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo. J Control Release. 2007;119(1):77-85.
3. Bala I, Hariharan S, Kumar MN. PLGA nanoparticles in drug delivery: the state of the art. Crit Rev Ther Drug Carrier Syst. 2004;21(5):387-422.
4. Dong Y, Feng SS. Poly(d, l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs. Biomaterials. 2005; 26(30):6068-6076.
5. Win KY, Feng SS. In vitro and in vivo studies on vitamin E TPGS-emulsified poly(D, L-lactic-co-glycolic acid) nanoparticles for paclitaxel formulation. Biomaterials. 2006;27(10):2285-2291.
6. Sahana DK, Mittal G, Bhardwaj V, Kumar MN. PLGA nanoparticles for oral delivery of hydrophobic drugs: influence of organic solvent on nanoparticle formation and release behavior in vitro and in vivo using estradiol as a model drug. J Pharm Sci. 2008;97(4):1530-1542.
7. Feng SS, Zeng W, Teng Lim Y, etal. Vitamin E TPGS-emulsified poly(lactic-co-glycolic acid) nanoparticles for cardiovascular restenosis treatment. Nanomedicine (Lond). 2007;2(3):333-344.
8. Feng SS, Mei L, Anitha P, Gan CW, Zhou W. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel. Biomaterials. 2009;30(19):3297-3306.
9. Win KY, Feng SS. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials. 2005;26(15):2713-2722.
10. Llabot JM, Salman H, Millotti G, Bernkop-Schnurch A, Allemandi D, Manuel Irache J. Bioadhesive properties of poly(anhydride) nanoparticles coated with different molecular weights chitosan. J Microencapsul. 2011;28(4):1-9.
11. Verma A, Stellacci F. Effect of surface properties on nanoparticle-cell interactions. Small. 2010; 6(1):12-21.
12. Chaudhuri A, Battaglia G, Golestanian R. The effect of interactions on the cellular uptake of nanoparticles. Phys Biol. 2011;8(4):046002.
13. Gao H, Shi W, Freund LB. Mechanics of receptor-mediated endocytosis. Proc Natl Acad Sci U S A. 2005;102(27):9469-9474.
14. Hariharan S, Bhardwaj V, Bala I, Sitterberg J, Bakowsky U, Ravi Kumar MN. Design of estradiol loaded PLGA nanoparticulate formulations: a potential oral delivery system for hormone therapy. Pharm Res. 2006;23(1):184-195.
15. Chithrani BD, Ghazani AA, Chan WC. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett. 2006;6(4):662-668.
16. Wang SH, Lee CW, Chiou A, Wei PK. Size-dependent endocytosis of gold nanoparticles studied by three-dimensional mapping of plasmonic scattering images. J Nanobiotechnology. 2010;8(12):33-45.
17. Lu F, Wu SH, Hung Y, Mou CY. Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles. Small. 2009;5(12):1408-1413.
18. Yang J, Zeng R, Kong T, etal. The effect of surface properties of gold nanoparticles on cellular uptake. 2007 IEEE NIH Life Sci Syst Appl Workshop. 2007;10(12):92-95.
19. Whitehead KA, Langer R, Anderson DG. Knocking down barriers: advances in siRNA delivery. Nature Reviews. 2009;8(2):129-138.
20. Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev. 2003;55(3): 329-347.
21. Smith KA, Jasnow D, Balazs AC. Designing synthetic vesicles that engulf nanoscopic particles. J Chem Phys. 2007;127(8):084703.
22. Bhardwaj V, Ankola DD, Gupta SC, Schneider M, Lehr CM, Kumar MN. PLGA nanoparticles stabilized with cationic surfactant: safety studies and application in oral delivery of paclitaxel to treat chemical-induced breast cancer in rat. Pharm Res. 2009;26(11):2495-2503.
23. Song KC, Lee HS, Choung Y, Cho KI, Ahn Y, Choi EJ. The effect of type of organic phase solvents on the particle size of poly(D, L-lactide-co-glycolide) nanoparticles. Colloids and Surfaces A: Physicochemical and Engineering Aspects. 2006;276(1-3):162-167.
24. Kwon HY, Lee JY, Choi SW, Jang YS, Kim JH. Preparation of PLGA nanoparticles containing estrogen by emulsification-diffusion method. Colloids and Surfaces A: Physicochemical and Engineering Aspects. 2001;182(1-3):123-130.
25. Peetla C, Labhasetwar V. Effect of molecular structure of cationic surfactants on biophysical interactions of surfactant-modified nanoparticles with a model membrane and cellular uptake. Langmuir. 2009; 25(4):2369-2377.
26. Sun B, Ranganathan B, Feng SS. Multifunctional poly(D, L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer. Biomaterials. 2008;29(4):475-486.
27. Huang J, Bu L, Xie J, etal. Effects of nanoparticle size on cellular uptake and liver MRI with polyvinylpyrrolidone-coated iron oxide nanoparticles. ACS Nano. 28;4(12):7151-7160.
28. Helfrich W. Elastic Properties of lipid bilayers-theory and possible experiments. Z Naturforsch C. 1973;C28(11):693-703.
29. Herant M, Heinrich V, Dembo M. Mechanics of neutrophil phagocytosis: behavior of the cortical tension. J Cell Sci. 2005;118(9):1789-1797.
30. Deserno M. Elastic deformation of a fluid membrane upon colloid binding. Phys Rev E. 2004;69(3):1-11.
31. Deserno M, Gelbart WM. Adhesion and wrapping in colloid-vesicle complexes. J Phys Chem B. 2002;106(21):5543-5552.
32. Desai MP, Labhasetwar V, Walter E, Levy RJ, Amidon GL. The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent. Pharm Res. 1997;14(11):1568-1573.
33. Oh WK, Kim S, Choi M, etal. Cellular uptake, cytotoxicity, and innate immune response of silica-titania hollow nanoparticles based on size and surface functionality. ACS Nano. 28;4(9):5301-5313.